The store will not work correctly when cookies are disabled.
3-(3-bromophenyl)-2-(8-hydroxyquinolin-2-yl)thiazolidin-4-one
ID: ALA4745980
PubChem CID: 162648100
Max Phase: Preclinical
Molecular Formula: C18H13BrN2O2S
Molecular Weight: 401.29
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1CSC(c2ccc3cccc(O)c3n2)N1c1cccc(Br)c1
Standard InChI: InChI=1S/C18H13BrN2O2S/c19-12-4-2-5-13(9-12)21-16(23)10-24-18(21)14-8-7-11-3-1-6-15(22)17(11)20-14/h1-9,18,22H,10H2
Standard InChI Key: YGCYUBKKJZBXKG-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
2.7762 -17.6975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7751 -18.5171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4831 -18.9260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4813 -17.2887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1899 -17.6939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1907 -18.5129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8992 -18.9200 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6075 -18.5092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6028 -17.6870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8937 -17.2837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4850 -19.7432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3209 -18.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4095 -19.7245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2095 -19.8913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6154 -19.1820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0662 -18.5769 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.8060 -20.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0272 -20.0201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4224 -20.5685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5952 -21.3681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3782 -21.6164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9797 -21.0663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5448 -20.6366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5540 -22.4144 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
21 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 401.29 | Molecular Weight (Monoisotopic): 399.9881 | AlogP: 4.48 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 4.04 | CX LogD: 4.03 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.69 | Np Likeness Score: -0.90 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |